10 February 2010
Avingtrans plc
(the "Company")
Director Shareholdings
Avingtrans plc (AIM:AVG), a manufacturer of critical components and associated
services to the medical, energy, industrial and global aerospace sectors, has
been notified today that on 10 February 2010 a number of the directors have, in
aggregate, bought 85,000 ordinary shares of 1p each ("Ordinary Shares").
Details of the purchases in the Company by the directors are as follows:
Roger McDowell, Chairman, bought a total of 60,000 Ordinary Shares in the
Company at a price of 35.8 pence per share. Following this share purchase,
Roger McDowell's beneficial holding in the Company is 2,258,909 Ordinary Shares
representing 8.9 per cent. of the Company's total voting rights.
Steve McQuillan, Chief Executive Officer, bought a total of 15,000 Ordinary
Shares in the Company at a price of 36 pence per share. Following this share
purchase, Steve McQuillan's beneficial holding in the Company is 55,000
Ordinary Shares representing 0.2 per cent. of the Company's total voting
rights.
Jeremy Hamer, Non Executive Director, purchased a total of 10,000 Ordinary
Shares in the Company at a price of 35 pence per share. Following this share
purchase, Jeremy Hamer's beneficial holding in the Company is 114,500 Ordinary
Shares representing 0.4 per cent. of the Company's total voting rights.
www.avingtrans.plc.uk
Enquiries:
Avingtrans plc, Steve McQuillan, CEO
Tel: +44(0)115 949 9020
KBC Peel Hunt
Richard Kauffer, Corporate Finance
Matthew Tyler, Corporate Broking
Tel: +44(0)20 7418 8900
Hansard Communications, John Bick
Tel: +44(0)20 7245 1100
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.